Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom, CuraGen Launch Drug Target Alliance

NEW YORK, March 13 - Sequenom and CuraGen will work together to probe disease-related genes by combining proteomics and population genetics, the companies said on Wednesday.

 

In the collaboration, Sequenom will identify genes relevant to disease through its population genetics approach, which applies whole-genome screens to discover relevant SNPs. CuraGen will apply proteomics techniques to characterize gene function, protein interaction and disease pathways, and thereby identify possible drug targets.

 

The companies did not discuss financial details of the agreement.

 

Sequenom has already identified more than 120 candidate genes, said company president and CEO Toni Schuh in a statement. CuraGen said its techniques will help validate these candidate genes, and ascertain which make the most viable targets for drug development.

 

As part of the partnership, CuraGen will also use Sequenom's SNP genotyping techniques to validate drug targets that it has already identfiied.

 

Sequenom, headquartered in San Diego, uses population genetics to identify common disease-related genes. It is a publicly owned company.

 

CuraGen, based in New Haven, Conn., uses functional genomics techniques to study genetic variations, gene expression, protein interactions, and potential drugs.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.